戻る Agenda
Panel Discussion
Speaker(s)
Moderator
Markham Luke, MD, PhD
FDA, United States
Director for Therapeutic Performance, Office of Generic Drugs, CDER
Panelists
Charles DiLiberti, MS
Montclair Bioequivalence Services, LLC, United States
President
Panelists
Xiaohui (Jeff) Jiang
FDA, United States
Division Deputy Director, Division of Therapeutic Performance, Office of Generic
Panelists
Darby Kozak, PhD
FDA, United States
Lead for Complex Drug Substances and Dosage Forms, OGD, CDER
Panelists
Andrew A. LeBoeuf, JD, MS
FDA, United States
Associate Director Regulatory Policy, ONDP, OND, CDER
Panelists
Sam G. Raney, PhD, MS
FDA, United States
Associate Director for Science, ORS, Office of Generic Drugs, CDER